DeepMed Research

UNIVERSITY OF CINCINNATI

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1819-01-01

Employees: 5.9K

Market Cap: -

Website: https://www.uc.edu/

Clinical Trials

Inhaled Nitric Oxide in Brain Injury

Phase 3

Completed

Conditions: Traumatic Brain Injury

Interventions: Drug: Inhaled Nitric Oxide
Drug: Placebo

First Posted Date: 2017-08-24

Last Posted Date: 2025-04-30

Lead Sponsor: University of Cincinnati

Target Recruit Count: 13

Registration Number: NCT03260569

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Pirfenidone for Progressive Fibrotic Sarcoidosis

Phase 4

Conditions: Sarcoidosis, Pulmonary

Interventions: Drug: Placebos
Drug: Pirfenidone

First Posted Date: 2017-08-24

Last Posted Date: 2017-09-28

Lead Sponsor: University of Cincinnati

Target Recruit Count: 60

Registration Number: NCT03260556

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Fractional CO2 Laser Therapy Versus 4% Topical Lidocaine Gel for Dyspareunia in Breast Cancer Survivors

Not Applicable

Conditions: Dyspareunia

Interventions: Device: CO2RE fractional laser therapy
Drug: 4% Topical Lidocaine Gel

First Posted Date: 2017-08-22

Last Posted Date: 2021-09-28

Lead Sponsor: University of Cincinnati

Target Recruit Count: 70

Registration Number: NCT03257670

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Resveratrol and Sirolimus in Lymphangioleiomyomatosis Trial

Phase 2

Completed

Conditions: Lymphangioleiomyomatosis

Interventions: Drug: Sirolimus
Drug: Resveratrol

First Posted Date: 2017-08-18

Last Posted Date: 2023-02-01

Lead Sponsor: University of Cincinnati

Target Recruit Count: 25

Registration Number: NCT03253913

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

The Effect of Yoga on Cardiac Sympathetic Innervation Evaluated by I-123 mIBG

Not Applicable

Withdrawn

Conditions: Heart Failure, Systolic

Interventions: Behavioral: Yoga training

First Posted Date: 2017-07-24

Last Posted Date: 2018-03-20

Lead Sponsor: University of Cincinnati

Registration Number: NCT03227393

Locations: 🇺🇸
University of Cincinnati Medical Center, Cincinnati, Ohio, United States

Cricopharyngeal Dysfunction and Esophageal Diverticulum

Recruiting

Conditions: Zenker Diverticulum
Progressive Dysphagia
Pharyngoesophageal Diverticulum

First Posted Date: 2017-06-15

Last Posted Date: 2023-09-13

Lead Sponsor: University of Cincinnati

Target Recruit Count: 500

Registration Number: NCT03187925

Locations: 🇺🇸
UC Health Otolaryngology-Head and Neck Surgery, Cincinnati, Ohio, United States

Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

Phase 3

Active, not recruiting

Conditions: LAM
Lymphangioleiomyomatosis

Interventions: Drug: Sirolimus

First Posted Date: 2017-05-12

Last Posted Date: 2024-12-24

Lead Sponsor: University of Cincinnati

Target Recruit Count: 60

Registration Number: NCT03150914

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States
🇺🇸
National Jewish Hospital, Denver, Colorado, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 5 locations

Study of Letrozole in Recurrent Gliomas

Early Phase 1

Recruiting

Conditions: Brain Tumor

Interventions: Drug: Letrozole Oral Tablet
Drug: Temozolomide

First Posted Date: 2017-04-20

Last Posted Date: 2023-12-13

Lead Sponsor: University of Cincinnati

Target Recruit Count: 39

Registration Number: NCT03122197

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Assessment of Safety of Air Travel in Patients With Pulmonary Langerhans Cell Histiocytosis

Completed

Conditions: Pulmonary Langerhans Cell Histiocytosis

First Posted Date: 2017-02-14

Last Posted Date: 2024-01-31

Lead Sponsor: University of Cincinnati

Target Recruit Count: 94

Registration Number: NCT03052101

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

Assessment of Safety of Air Travel in Patients With Birt-Hogg-Dube Syndrome

Completed

Conditions: Birt-Hogg-Dube Syndrome

First Posted Date: 2017-02-02

Last Posted Date: 2024-01-31

Lead Sponsor: University of Cincinnati

Target Recruit Count: 104

Registration Number: NCT03040115

Locations: 🇺🇸
University of Cincinnati, Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy